Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glecaprevir/Pibrentasvir in non-cirrhotic chronic HCV GT1-6 adults (with or without HIV, treatment-naïve or experienced)
CTR20170274Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glecaprevir + pibrentasvir in chronic hepatitis C (CHC), hepatitis C virus infection, human immunodeficiency virus infection (HIV), sponsored by AbbVie Inc.. Started Jul 2017; status: completed.
02
Drugs
glecaprevir + pibrentasvir
03
Conditions
chronic hepatitis C (CHC)hepatitis C virus infectionhuman immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on CTR20170274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170274.